Literature DB >> 1779700

Agonist-induced Ca2+ mobilization in the rat submandibular gland during aging and subsequent to chronic propranolol treatment.

J E Melvin1, A C O'Connell, L Koek, W H Bowen.   

Abstract

The effects of age and chronic propranolol treatment on the agonist-induced rise in intracellular free Ca2+ ([Ca2+]i), an index for the coupling of receptor-second messenger generation, was studied using a dispersed rat submandibular gland preparation. Muscarinic stimulation (10 microns carbachol) caused a rapid (T1/2 less than 2 s) and dramatic (approximately 4.5-fold) rise in [Ca2+]i followed by a lower sustained increase (approximately 3-fold) in [Ca2+]i as measured directly with the Ca(2+)-sensitive fluorescent probe, fura-2. The magnitude and the rate of increase of the initial rise in [Ca2+]i and the level of the sustained increase in [Ca2+]i were not different between 2- an 21-month-old rats. Stimulation in a Ca(2+)-free medium reduced the initial agonist-induced increase in [Ca2+]i by approximately 35-40%, while the sustained increase was abolished by the removal of extracellular Ca2+ from cells in both young and old rats. Chronic treatment for 30 days with 20 mg/kg propranolol, a beta-adrenergic antagonist, did not significantly alter the ability of dispersed submandibular cells in old rats to mobilize Ca2+ during agonist stimulation or influence the in vivo stimulated gland output. These results suggest that the agonist-induced rise in [Ca2+]i is not altered by aging or by chronic treatment of aged rats with propranolol and, therefore, receptor-second messenger coupling remains intact.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779700     DOI: 10.1016/0047-6374(91)90005-k

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  1 in total

1.  Ca2+, calmodulin and phospholipids regulate nitricoxide synthase activity in the rabbit submandibular gland.

Authors:  Y Yamamoto; O Katsumata; S Furuyama; H Sugiya
Journal:  J Comp Physiol B       Date:  2004-09-23       Impact factor: 2.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.